Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Levosimendan Administration in High Risk Cardiac Surgery Patients With Pulmonary Hypertension

NCT04599816 is registered in ClinicalTrials.gov with Aretaieion University Hospital as lead sponsor.

NCT NCT04599816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04599816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Levosimendan Administration in High Risk Cardiac Surgery Patients With Pulmonary Hypertension
Lead sponsor
Aretaieion University Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 17, 2020
Completion date
October 17, 2022
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac failure, hypertension, pulmonary, pulmonary vascular resistance abnormality